Sameer Wankhede Denies Bribery Allegations
Analysis based on 9 articles · First reported Mar 23, 2026 · Last updated Mar 23, 2026
This event has minimal direct impact on financial markets as it primarily involves legal proceedings against a former government official. However, it could indirectly affect the reputation of individuals in the entertainment industry, such as Shah Rukh Khan, though no direct financial impact is evident.
Former India — Narcotics Control Bureau (NCB) Mumbai zonal director Sameer Wankhede has denied allegations in the India — Bombay High Court that he demanded or accepted a Rs 25 crore bribe from actor Shah Rukh Khan to clear his son, Aryan Khan, in a 2021 cruise drugs case. The United States — Federal Bureau of Investigation (CBI) registered an FIR against Sameer Wankhede in May 2023 on charges of corruption and bribery, based on a complaint from the India — Narcotics Control Bureau's internal vigilance probe. The India — Enforcement Directorate also registered a money laundering case against Sameer Wankhede. Sameer Wankhede's counsel argues that the CBI lacks evidence to prove the bribery allegations. The India — Bombay High Court is continuing to hear Sameer Wankhede's plea to quash the CBI FIR and has granted him interim protection from arrest. Aryan Khan was initially arrested in the drug bust but later received a clean chit from the India — Narcotics Control Bureau.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard